|
Rexam is a leading global consumer packaging company. It is the largest beverage can maker in the world and a global leader in rigid plastic packaging. Three things characterise us – leadership in our industry, our commitment to innovation and our passion to deliver exceptional value. With 23,500 people in more than 20 countries, Rexam’s sales from ongoing operations are approximately £3.6 billion.
Through the acquisition of O-I Plastics, Rexam has reinforced its leadership in healthcare packaging, drug delivery systems and medical devices.
Rexam Pharma has a strong focus on the pharmaceutical industry’ needs with comprehensive resources in innovation, development & industrialization and full GMP manufacturing. From unmet market needs to fully validated drug delivery solutions, we implement new ways to improve patients’ lives.
Our expertise in plastic injection and high-speed automated assembly enables us to offer high quality products for all delivery routes.
- Inhalation: dry powder inhalers, metering valves and actuators, dose counters
- Ophthalmics: eyedroppers and devices
- Nasal & buccal: spray pumps and applicators, bottles
- Dermal & transdermal: metering systems to deliver lotions, gels and creams
- Parenteral devices: injection pens, implanters, safety systems for syringes
- Oral: pill jars and closures
- Medical and diagnostics: plastic components and assemblies for medical devices and diagnostic disposables
From design to production, Rexam Pharma leads with accuracy, cost-effectiveness and on-time delivery of the product.
Our global operations allow us to partner closely with pharmaceutical, biotech and medical device companies.
For further information, visit Rexam’s website atwww.rexam.com/pharma
|
